Clover Health Investments - Class A opened lower at $4.53, compared with its previous close of $4.58. In the last trading session, the stock traded between $4.35 and $4.57. It showed a downward intraday trend.
An investment of $100 made 5 years ago in Clover Health Investments - Class A is now worth
$ 58.07
resulting in a loss of
$ 41.93 (41.93%)
Note: Past profits do not guarantee future returns.
Rating from 4 Analysts
Today's Change
$-0.23 (-4.91%)
Day High
$4.57
Day Low
$4.35
Day Open
$4.53
Prev Close
$4.58
Volume
18,58,425
1W Return
-7.83%
1M Return
0.69%
3M Return
3.08%
6M Return
68.80%
1Y Return
19.64%
Market Cap ($ Mn)
1,896
PE Ratio
-
PB Ratio
5.93
PEG Ratio
-
ROE
-25.60%
ROCE
-23.68%
EPS (TTM)
$0.05
1 Week
-7.83%
1 Month
0.69%
3 Months
3.08%
6 Months
68.80%
9 Months
91.85%
Clover Health earns top Medicare Advantage ratings in three states
Clover Health earned top distinctions in U.S. News & World Report's 2027 Medicare Advantage ratings in New Jersey, Georgia, and South Carolina. The company ranked #1 among non-SNP PPO plans with over 2,000 members for the third consecutive year on HEDIS measures. Clover achieved a HEDIS score of 4.82 out of 5 Stars, highlighting strong performance in preventive and continuity of care. Plans are available to 5.2 million Medicare-eligible beneficiaries across five states during the 2027 enrollment period.
10 days agoClover Health shares rise 6% as CMS awards PPO plans 5 stars
Clover Health shares rose 6.33% to $4.868 following CMS 5-star rating announcement. Medicare Advantage PPO plans received 5 stars; HMO plans received 4.5 stars for 2027. Enrollment grew 48% YoY to over 157,000 members in H1 2026. Court ruling excluded 20 measures from scoring, boosting PPO rating from 4.5 to 5 stars.
21 days agoClover Health Q3FY26 Results: Earnings call set for Nov 4, 2026
Clover Health releases Q3FY26 results on Nov 4, 2026. Conference call scheduled for 5:00 pm ET same day. Webcast archived for 12 months on IR site. Focus on Medicare Advantage plans and tech platform.
22 days agoClover Health appoints Torricelli and Miller to board of directors
Clover Health appointed Robert Torricelli and Dr. Brian J. Miller to its Board of Directors. Torricelli joins the Audit Committee; Miller joins the Clinical Committee. Appointments fill two vacancies, bringing the total number of directors to nine.
1mo agoClover Health to present at Jefferies and Deutsche Bank conferences
Clover Health Investments Corp (NASDAQ: CLOV) joins two investor conferences in September 2026. Interim CFO Clay Thornton presents at Jefferies event on September 15 at 1:40 pm ET. Thornton also participates in Deutsche Bank Healthcare Summit on September 16. Live webcast of Jefferies presentation available via investor relations site.
1mo agoClover Health raises FY26 sales guidance to $3B range
Clover Health Investments increases its FY2026 sales guidance to $2.92 billion-$3.00 billion from $2.81 billion-$2.92 billion. The new outlook beats the $2.91 billion consensus estimate, reflecting strong operational momentum and confidence in future member growth.
2mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $410.91 | +0.94% | $3,68,830.76M | 25.27 | |
| $90.33 | +0.42% | $1,15,529.36M | 24.49 | |
| $422.02 | +1.84% | $91,179.95M | 17.46 | |
| $298.41 | +1.16% | $78,851.86M | 11.53 | |
| $415.80 | +1.17% | $50,034.33M | 36.44 | |
| $68.62 | +2.34% | $33,971.57M | - | |
| $198.95 | +0.43% | $10,385.19M | 2,222.22 | |
| $30.79 | +1.02% | $8,420.11M | 23.62 | |
| $28.40 | +1.90% | $2,179.05M | 28.26 | |
| $8.06 | -1.47% | $1,671.93M | 71.71 |
An investment of $100 made 5 years ago in Clover Health Investments - Class A is now worth
$ 58.07
resulting in a loss of
$ 41.93 (41.93%)
Note: Past profits do not guarantee future returns.
